Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.585 USD | +0.32% | +1.96% | -11.36% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.36% | 77.48M | |
+1.69% | 42.86B | |
+11.77% | 42.74B | |
+45.21% | 41.36B | |
-8.83% | 27.68B | |
+7.97% | 25.15B | |
-23.23% | 18.63B | |
+30.42% | 12.37B | |
-2.44% | 11.92B | |
+7.54% | 11.21B |
- Stock Market
- Equities
- CRVS Stock
- News Corvus Pharmaceuticals, Inc.
- Corvus Pharmaceuticals Says Preclinical Data Showed Soquelitinib Was Active in Six Inflammatory, Immune Disease Models